830PSynthetic DNA immunotherapy in biochemically relapsed prostate cancer. (23rd October 2018) - Shore, N; Heath, E I; Nordquist, L T; Cheng, H; Bhatt, K; Morrow, M; McMullan, T; Kraynyak, K; Lee, J; Sacchetta, B; Liu, L; Rosencranz, S; et al.